Health Quality Improvement Programme | December 2018 | Bowel Cancer Audit
The latest annual National Bowel Cancer Audit from the Health Quality Improvement Programme (HQIP) details data from over 30,000 patients diagnosed with bowel cancer between 01 April 2016 and 31 March 2017.
This audit report describes some ongoing improvements such as mortality rates following both elective and emergency surgery falling over the past five years and increased numbers of operations being performed laparoscopically.
This year’s report has also described geographical variation in chemotherapy administration and further work is required to better describe and understand this. It is encouraging to see that there has been a reducing trend of deaths in hospital from 2011 to 2016 (46.2% – 34.6%) (Source: HQIP) .
University of Edinburgh | November 2018| Bowel cancer waiting times figures revealed
Bowel cancer is the fourth most common cancer type, now researchers from the University of Edinburgh have shown that it takes 10% of patients in England and Wales more than a year from recognising the symptoms to receiving treatment for their bowel cancer. They found that 10% of people with bowel cancer in Scotland waited more than 8 months to start treatment.
This international study included anonymised medical data from 3000 patients and their doctors in Australia, and Canada alongside the UK. Among their findings people in Wales took the longest to contact their GP once they had a health concern. Patients in Wales also waited the longest time (168 days) to commence treatment, which contrasts with Denmark (77 days. Researchers found that men and women in Wales took the longest to contact their doctor once they had noticed a health concern or symptom (Source: University of Edinburgh).
Health Quality Improvement Programme | August 2018| National Bowel Cancer Audit: The feasibility of reporting patient outcome measures as part of of a national colorectal cancer audit
Health Quality Improvement Programme (HQIP) has published the National Bowel Cancer Audit: The feasibility of reporting patient outcome measures
NHS England’s National Cancer PROMs Programme of the National Survivorship Initiative2 collected Patient Reported Outcome Measures (PROMs) for colorectal cancer patients in a one-off study in 2013. Patients were between one- and three-years from diagnosis at the point of being surveyed.
The aim of this study was to link the Patient Reported Outcome Measures (PROMs) for colorectal cancer patients in a one-off study in 2013, survey data to the National Bowel Cancer Audit (NBOCA) data to establish the feasibility of reporting PROMs as part of a national clinical audit. This was assessed according to i) the characteristics of responders compared to all eligible patients ii) the representativeness of the responders at different points along their pathway from diagnosis, iii) hospital trust variation in response rate, and iv) the validity of the measures in comparison to NBOCA measures (Source: HQIP).
The full report is available from HQIP here
Guidance for providers of bowel scope screening within the NHS Bowel Cancer Screening Programme in England | Public Health England
The UK National Screening Committee recommended the addition of bowel scope screening alongside the existing guaiac faecal occult blood test (gFOBT) following a clinical trial and 11 years of follow-up. These standard operating procedures (SOPs) help commissioners and providers in establishing and implementing bowel scope screening.
University of Edinburgh | June 2018 | Aspirin’s anti-cancer effects revealed
Researchers at the University of Edinburgh have discovered aspirin blocks a key process linked to tumour formation. Although aspirin is recognised for its ability to reduce an individual’s risk of developing colon cancer-if taken regularly- its tumour fighting properties have been little understood. The team looked at the impact of taking aspirin to fight bowel cancer; focusing on a structure found inside cells called the nucleolus. They tested aspirin tumour biopsies removed from patients with colon cancer, and cells grown in the lab. Their research discovered that aspirin blocks TIF-IA a key molecule essential to the functioning of the nucleolus (via University of Edinburgh).
Full press release from University of Edinburgh here
Bowel Cancer UK | Bowel Cancer Awareness Month 2018
April 2018 is bowel cancer awareness month and Bowel Cancer UK has produced a range of resources to raise awareness. Their mission is to ensure that by 2050, no-one will die of bowel cancer.
Bowel cancer is the UK’s second biggest cancer killer however it shouldn’t be because it is treatable and curable especially if diagnosed early. Nearly everyone diagnosed at the earliest stage will survive bowel cancer but this drops significantly as the disease develops. (Bowel Cancer UK)
The resources including more information about the symptoms of bowel cancer are available at Bowel Cancer UK
The poster can be downloaded from Bowel Cancer UK here